| Hebert LA, Kusek JW, Greene T, Agodoa LY, Jones CA, Levey AS, Breyer JA, Faubert P, Rolin HA, Wang SR. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension 1997 Sep;30(3 Pt 1):428-35. |
| Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study. J Am Soc Nephrol 1996 Apr;7(4):556-66. |
| Levey AS, Adler S, Caggiula AW, England BK, Greene T, Hunsicker LG, Kusek JW, Rogers NL, Teschan PE. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am J Kidney Dis 1996 May;27(5):652-63. |
| Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study. J Am Soc Nephrol 1996 Dec;7(12):2616-26. |
| Fotheringham J, Campbell MJ, Fogarty DG, El Nahas M, Ellam T. Estimated albumin excretion rate versus urine albumin-creatinine ratio for the estimation of measured albumin excretion rate: derivation and validation of an estimated albumin excretion rate equation. Am J Kidney Dis 2014 Mar;63(3):405-14. Epub 2013 Sep 29. |
| Schluchter MD. Estimating correlation between alternative measures of disease progression in a longitudinal study. Modification of Diet in Renal Disease Study. Stat Med 1990 Oct;9(10):1175-88. |
| Milas NC, Nowalk MP, Akpele L, Castaldo L, Coyne T, Doroshenko L, Kigawa L, Korzec-Ramirez D, Scherch LK, Snetselaar L. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. J Am Diet Assoc 1995 Nov;95(11):1295-300. |
| Menon V, Wang X, Greene T, Beck GJ, Kusek JW, Marcovina SM, Levey AS, Sarnak MJ. Factors associated with serum leptin in patients with chronic kidney disease. Clin Nephrol 2004 Mar;61(3):163-9. |
| Gillis BP, Averbach FM, Caggiula AW, Jones FL, Naujelis J, Maurer E, Meehan RJ, Yamamoto ME, Mowry K, Meehan RJ. Features of the nutrient database and analysis system for the Modification of Diet in Renal Disease Study. Control Clin Trials 1994 Feb;15(1):44-58. |
| Ix JH, Shlipak MG, Sarnak MJ, Beck GJ, Greene T, Wang X, Kusek JW, Collins AJ, Levey AS, Menon V. Fetuin-A is not associated with mortality in chronic kidney disease. Kidney Int 2007 Dec;72(11):1394-9. Epub 2007 Sep 19. |
| Menon V, Greene T, Pereira AA, Wang X, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ. Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. J Am Soc Nephrol 2005 Nov;16(11):3411-7. Epub 2005 Oct 5. |
| Hebert LA, Greene T, Levey A, Falkenhain ME, Klahr S. High urine volume and low urine osmolality are risk factors for faster progression of renal disease. Am J Kidney Dis 2003 May;41(5):962-71. |
| Menon V, Wang X, Greene T, Beck GJ, Kusek JW, Selhub J, Levey AS, Sarnak MJ. Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins. Kidney Int 2005 Apr;67(4):1539-46. |
| Sarnak MJ, Wang SR, Beck GJ, Kusek JW, Selhub J, Greene T, Levey AS. Homocysteine, cysteine, and B vitamins as predictors of kidney disease progression. Am J Kidney Dis 2002 Nov;40(5):932-9. |
| Ku E, Kopple JD, Johansen KL, McCulloch CE, Go AS, Xie D, Lin F, Hamm LL, He J, Kusek JW, Navaneethan SD, Ricardo AC, Rincon-Choles H, Smogorzewski M, Hsu CY, CRIC Study Investigators. Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality. Am J Kidney Dis 2018 May;71(5):657-665. Epub 2017 Dec 6. |
| Gillis BP, Caggiula AW, Chiavacci AT, Coyne T, Doroshenko L, Milas NC, Nowalk MP, Scherch LK. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. J Am Diet Assoc 1995 Nov;95(11):1288-94. |
| Kopple JD, Berg R, Houser H, Steinman TI, Teschan P. Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int Suppl 1989 Nov;27:S184-94. |
| Laidlaw SA, Berg RL, Kopple JD, Naito H, Walker WG, Walser M. Patterns of fasting plasma amino acid levels in chronic renal insufficiency: results from the feasibility phase of the Modification of Diet in Renal Disease Study. Am J Kidney Dis 1994 Apr;23(4):504-13. |
| Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005 Feb;16(2):459-66. Epub 2004 Dec 22. |
| Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 1997 Jun;51(6):1908-19. |
| Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003 Jan;41(1):1-12. |
| Buckalew VM Jr, Berg RL, Wang SR, Porush JG, Rauch S, Schulman G. Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. Am J Kidney Dis 1996 Dec;28(6):811-21. |
| Kusek JW, Coyne T, de Velasco A, Drabik MJ, Finlay RA, Gassman JJ, Kiefer S, Powers SN, Steinman TI. Recruitment experience in the full-scale phase of the Modification of Diet in Renal Disease Study. Control Clin Trials 1993 Dec;14(6):538-57. |
| Reduction of dietary protein and phosphorus in the Modification of Diet in Renal Disease Feasibility Study. The MDRD Study Group. J Am Diet Assoc 1994 Sep;94(9):986-90; quiz 991-2. |
| Dolecek TA, Olson MB, Caggiula AW, Dwyer JT, Milas NC, Gillis BP, Hartman JA, DiChiro JT. Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. J Am Diet Assoc 1995 Nov;95(11):1307-12. |
